US 12048747
Substituted piperidine Degronimers for Target Protein degradation
granted A61KA61K31/45A61K31/454
Quick answer
US patent 12048747 (Substituted piperidine Degronimers for Target Protein degradation) held by C4 THERAPEUTICS, INC. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/45, A61K31/454, A61K31/4545, A61K31/4709